+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2013-10-10Number of Pages: 97

Transcriptomics Technologies Market (Microarrays, PCR, Gene Regulation and Next Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Global Transcriptomics Technologies Market: Snapshot

The global transcriptomics technologies market is expected to experience noteworthy growth in the forthcoming years. The growing interest of pharmaceutical companies in the development of targeted and personalized therapeutics is creating a demand for the identification of disease-specific biomarkers. This trend is contributing significantly to the growth of the market. Moreover, the increasing investments in the research and development activities along with the continual improvement in the healthcare infrastructure is providing a substantial boost to the growth of the market.

The future of the global transcriptomics technologies market looks bright with the rising focus on the development of bioinformatics tools and services. The increasing research and development activities are creating a pressing need among corporate, academic, and research institutes to develop sophisticated and reliable software to manage the plethora of research data. Hence, there are immense opportunities for both software and life science companies to develop advanced bioinformatics tools. Owing to all these factors, the opportunity in the global transcriptomics technologies market was pegged at US$2.55 bn in 2015 and is poised to expand at a CAGR of 15.9% between 2013 and 2019, reaching US$4.62 bn by 2019.

Polymerase Chain Reaction to Take a Dive of Success Owing to their High Process Efficiency

On the basis of technology, polymerase chain reaction (PCR) will continue to lead the market in terms of revenue until 2019. Benefits offered by PCR such as high process efficiency, better precision, and greater amplification are boosting its uptake. Moreover, wider application areas along with versatility in approach and incessant product modification are catalyzing the growth of the segment.

The next generation sequencing (NGS) segment is likely to tread along a healthy growth track, expanding at a CAGR greater than 19.0% during the forecast period. Factors such as rapid technological advancements enabling the analysis of cellular transcriptome from several dimensions, expanding application areas of NGS, and the increasing outsourcing of sequencing technologies are propelling the growth of the segment.

Based on applications, drug discovery and research was the dominant segment in terms of revenue in 2015 and will maintain its leadership until 2019. The rigorous research and development initiatives in the field of genomics and proteomics are boosting the adoption of transcriptomics technologies in drug discovery and research. The segment is expected to expand at a significant CAGR of 18.2% during the same period.

North America to Lead Due to Rigorous Research and Development Activities Coupled with Increasing Investments

Geographically, the global transcriptomics technologies market will continue to be dominated by North America until 2019. The region is primarily driven by the presence of numerous biotech companies with well-established infrastructure and advanced technological platforms. The increasing investment from private organizations for transcriptomics research is assisting companies in the region in developing targeted therapeutics. Moreover, the presence of various academic and research institutes pursuing transcriptome studies is fuelling the growth of the region. The region will command 39% in the overall market revenue by 2019.

Asia Pacific is estimated to exhibit a CAGR of 18.0% during the same period. The tremendous growth of the region can be attributed to the consistent growth in the research and development activities in the field of life sciences. The rising trend of outsourcing clinical research and medical research, particularly in India and China, is fuelling the advancements in life sciences, thereby promoting the growth of the transcriptomics technologies market in the region.

Europe and Rest of the World are expected to rise at the similar pace during the forecast horizon. The leading players in the market are Affymetrix Inc., Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina Inc., Life Technologies Corporation, and Thermo Fisher Scientific.

Table of Content

 

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

1.4 List of Abbreviations

 

Chapter 2 Executive Summary

 

Chapter 3 Market Overview

3.1 Introduction

      3.1.1 Market Potential of Transcriptomics Technologies

      3.1.2 Future Scenario of Transcriptomics

      3.1.3 Market Dynamics

3.2 Market Drivers

      3.2.1 Technological Advancements

      3.2.2 Rising Preference for Personalized Medicine from both ends (Manufacturers and Consumers)

      3.2.3 Increasing Research and Development Investments

      3.2.4 Impact Analysis of Market Drivers

3.3 Market Restraints

      3.3.1 Lack Of Efficient Data Analysis Tools

      3.3.2 Impact Analysis of Market Restraints

3.4 Market Opportunities

      3.4.1 Focus on Development of Bioinformatics Tools and Services

3.5 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market

      3.5.1 Bargaining Power Of Buyers

      3.5.2 Bargaining Power Of Suppliers

      3.5.3 Threat of Substitutes

      3.5.4 Threat of New Entrants

      3.5.5 Competitive Rivalry

3.6 Market Attractiveness Analysis: Global Transcritpomics Technologies Market, By Geography

 

Chapter 4 Global Transcriptomics Technologies Market, By Technology

4.1 Introduction

4.2 Microarrays

      4.2.1 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.2.2 Polymerase Chain Reaction (PCR)

               4.2.2.1 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.2.3 Gene Regulation Technologies (RNA Interference Technology)

              4.2.3.1 Global Gene Regulation Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.2.4 Next Generation Sequencing (NGS)

              4.2.4.1 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

 

Chapter 5 Global Transcriptomics Technologies Market, By Application

5.1 Overview

5.2 Clinical Diagnostics

      5.2.1 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

5.3 Drug Discovery And Research

      5.3.1 Global Drug Discovery and Research Market, Size and Forecast, 2011 - 2019 (USD Million)

5.4 Bioinformatics

      5.4.1 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)

5.5 Comparative Transcriptome Studies

      5.5.1 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)

 

Chapter 6 Global Transcriptomics Technologies Market, By Geography

6.1 Overview

      6.1.1 Global Transcriptomics Technologies Market, By Geography, Size and Forecast, 2011 – 2019 (USD Million)

      6.1.2 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %)

6.2 North America

      6.2.1 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

6.3 Europe

      6.3.1 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

6.4 Asia-Pacific

      6.4.1 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

6.5 Rest of the World (Row)

      6.5.1 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

 

Chapter 7 Competitive Landscape

7.1 Market Share By Key Players: Global Transcriptomics Technologies Market, 2012 (%)

 

Chapter 8 Recommendations

8.1 Collaboration with Academic and Research Institutes

8.2 Focus on Imparting Education about Genomic Medicine

 

Chapter 9 Company Profiles

9.1 Affymetrix, Inc.

      9.1.1 Company Overview

      9.1.2 Financial Overview

      9.1.3 Product Portfolio

      9.1.4 Business Strategies

      9.1.5 Recent Developments

9.2 Agilent Technologies, Inc.

      9.2.1 Company Overview

      9.2.2 Financial Overview

      9.2.3 Product Portfolio

      9.2.4 Business Strategies

      9.2.5 Recent Developments

9.3 Bio-Rad Laboratories, Inc.

      9.3.1 Business Overview

      9.3.2 Financial Overview

      9.3.3 Product Portfolio

      9.3.4 Business Strategies

      9.3.5 Recent Developments

9.4 Danaher Corporation

      9.4.1 Business Overview

      9.4.2 Financial Overview

      9.4.3 Product Portfolio

      9.4.4 Business Strategies

      9.4.5 Recent Developments

9.5 F. Hoffmann-La Roche Ltd.

      9.5.1 Company Overview      

      9.5.2 Financial Overview

      9.5.3 Product Portfolio

      9.5.4 Business Strategies

      9.5.5 Recent Developments

9.6 Illumina, Inc.

      9.6.1 Company Overview

      9.6.2 Financial Overview

      9.6.3 Product Portfolio

      9.6.4 Business Strategies

      9.6.5 Recent Developments

9.7 Life Technologies Corporation

      9.7.1 Company Overview

      9.7.2 Financial Overview

      9.7.3 Product Portfolio

      9.7.4 Business Strategies

      9.7.5 Recent Developments

9.8 LC Sciences, LLC

      9.8.1 Company Overview

      9.8.2 Financial Overview

      9.8.3 Product Portfolio

      9.8.4 Business Strategies

      9.8.5 Recent Developments

9.9 Qiagen N.V.

      9.9.1 Company Overview

      9.9.2 Financial Overview

      9.9.3 Product Portfolio

      9.9.4 Business Strategies

      9.9.5 Recent Developments

9.10 Sigma-Aldrich Corporation

      9.10.1 Company Overview

      9.10.2 Financial Overview

      9.10.3 Product Portfolio

      9.10.4 Business Strategies

      9.10.5 Recent Developments

9.11 Thermo Fisher Scientific

      9.11.1 Company Overview

      9.11.2 Financial Overview

      9.11.3 Product Portfolio

      9.11.4 Business Strategies

      9.11.5 Recent Developments

List of Figures

 

FIG. 1 Central Dogma : Transcriptomics Technologies Market

FIG. 2 Transcriptomics Technologies: Market Segmentation

FIG. 3 Global Transcriptomics Technologies Market, By Technology, 2012 (USD Million)

FIG. 4 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market

FIG. 5 Market Attractiveness Analysis: Global Transcriptomics Technologies Market, By Geography

FIG. 6 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 7 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 8 Global Gene Regulation Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 9 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 10 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 11 Global Drug Discovery Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 12 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 13 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 14 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %)

FIG. 15 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 16 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 17 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 18 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 19 Market Share Analysis: Global Transcriptomics Technologies Market, 2012 (%)

FIG. 20 Affymetrix, Inc., Annual Revenue:  2010 – 2012 (USD Million)

FIG. 21 Agilent Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 22 Bio-Rad Laboratories, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 23 Danaher Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 24 F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 – 2012 (USD Million) (1 CHF = 1.09 USD)

FIG. 25 Illumina, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 26 Life Technologies Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 27 Qiagen N.V., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 28 Sigma Aldrich Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 29 Thermo Fisher Scientific, Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

 

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Transcriptomics Technologies Market

TABLE 3 Impact Analysis of Market Drivers

TABLE 4 Impact Analysis of Market Restraints

TABLE 5 Global Transcriptomics Technologies Market, By Technology, Size and Forecast, 2011-2019 (USD Million)

TABLE 6 Global Transcriptomics Technologies Market, By Application, Size and Forecast, 2011-2019 (USD Million)

TABLE 7 Global Transcriptomics Technologies Market, By Geography, Size and Forecast,     2011 – 2019(USD Million)

The report on the global transcriptomics technologies market bundles all factors that have influenced this market over the past few years and utilizes clear and effective processes and methodologies to ascertain the future of the global transcriptomics technologies market. The report states that the global transcriptomics technologies market is expected to expand handsomely over the next few years.

The global transcriptomics technologies market is divided in terms of technology, applications, and geography. The report then quantifies the leading segments according to each criterion in order to simplify the evaluation process of the global transcriptomics technologies market. This involves defining all market drivers and restraints that propel and hinder the global transcriptomics technologies market, respectively.

The key driving factor of the global transcriptomics technologies market is the growing requirement for all products in the market for personalized healthcare and comparison diagnostics. Other driving factors for the global transcriptomics technologies market include the availability of sufficient gear in laboratories as well as healthcare organizations, along with an increasing awareness of the benefits that transcriptomics technologies can bring to the healthcare sector.

The report explains key aspects that could affect the global transcriptomics technologies market in the coming few years.

The report utilizes proven research methods such as SWOT analysis and Porter’s five forces analysis to update the report’s user with the global transcriptomics technologies market’s determinant macro and micro factors as well as the value chain.

Overview of the Global Transcriptomics Technologies Market 

The global transcriptomics technologies market is exhibiting a 15.90% CAGR from 2013 to 2019. The market was valued at US$1.65 bn in 2012. The consistent growth pattern of the market will lead to a value of US$4.6 bn for the global transcriptomics technologies market by the end of 2019.

The key segments of the global transcriptomics technologies market according to technology are gene regulation technologies, microarrays, PCR, and NGS. Transcriptomics technologies find major use in gene expression patterns and drug discovery. Transcriptomics technologies are also applied in the clinical diagnosis of central nervous system disorders, cardiovascular disorders, and cancers. Transcriptome analysis tools offer accurate insights into gene sequence identification, gene expression patterns, and gene regulation mechanisms.

The global transcriptomics technologies market could be restrained by factors such as the non-availability of resources and tools that help in analyzing critical and complex data, the lack of tools that allow for biology computation, and the overall lack of skilled manpower with domain expertise.

The global transcriptomics technologies market is led by Asia Pacific, which has the fastest growth rate, due to the sharply increasing population in the region, coupled with the consequent boost in supply by the vendor base in the region. North America is the largest regional segment of the global transcriptomics technologies market and held a revenue share of 35.0% in 2012.

Companies mentioned in the research report 
 

The top players in the global transcriptomics technologies market are Affymetrix, Inc., Thermo Fisher Scientific, Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina, Inc., and Life Technologies Corporation. 

Key segments of the Global Transcriptomics Technologies Market

Transcriptomics Technologies Market, by Technology

  • Microarrays
  • Polymerase Chain Reaction (PCR)
  • Gene Regulation Technologies
  • Next Generation Sequencing (NGS)

Transcriptomics Technologies Market, by Applications

  • Clinical Diagnostics
  • Drug Discovery and Research
  • Bioinformatics
  • Comparative Transcriptomics Studies

Major regions analyzed under this research report are: 

  • Europe
  • North America 
  • Asia Pacific 
  • Rest of the World 

This report gives you access to decisive data such as:

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements 
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments


 
 
Back To Top